Ibm mindup Patch#

'We’ve learned that there is no need for a solution based on our technology. Hemonitor initially envisioned using ultrasound technology for monitoring internal bleeding and began to meet with physicians and directors of ICU trauma. Both were biomedical engineering graduates of the prestigious Technion Israel Institute of Technologyin Israel. The concept for the technology evolved from a joint project carried out by Mayblum and his co-founder Samer Toume. 'There have been several attempts to solve the need in clinical practice by doing indirect non-invasive measurements of other parameters to assume what the cardiac output is but there is still no direct solution which is non-invasive or continuous,' Hemonitor CEO and co-founder Tom Mayblum told Medtech Insight.

Ibm mindup Patch#

One Israeli start-up, Hemonitor, is developing a new non-invasive solution - a hemodynamic monitor that uses a wearable ultrasound patch technology for continuous monitoring of blood flow. The high cost associated with the procedure also restricts healthcare professionals from measuring the cardiac output of every patient entering ICU or sedated in surgery.

While effective, this technique of measuring cardiac output is invasive and not without risks. The current gold standard, thermodilution, involves inserting a thermistor-tipped catheter into the pulmonary artery via a peripheral vein. The crucial need for a less-invasive method of measuring cardiac output has long been the focus of development for medical device companies.